V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund 13F holdings
Dodge & Cox Stock Fund's Portfolio
- Portfolio value:
- $119.64B≈
- # of securities:
- 89
- Reported for:
- 31 Dec 2025 (Q4)
- Latest filing date:
- 27 Feb 2026
What stocks did Dodge & Cox Stock Fund own in 2025 Q4?
What was Dodge & Cox Stock Fund's 2025 Q4 portfolio?
Dodge & Cox Stock Fund has disclosed a total of 89 security holdings in their (2025 Q4) SEC filing(s) with portfolio value of $119,636,959,096.
Dodge & Cox Stock Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Dodge & Cox Stock Fund's original SEC reports (2025 Q4) are the official SEC institutional disclosure documents covering all reported equity positions.
85 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Charles Schwab Corp
|
4.36%
|
52,225,135
|
$99.91
|
+8.07%($107.98)
|
$5,217,813,238
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-8.88% (-5.09M)
|
-0.42%
|
|
|
|
RTX Corp
|
3.86%
|
25,204,600
|
$183.40
|
+22.30%($224.29)
|
$4,622,523,640
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-7.12% (-1.93M)
|
-0.29%
|
|
|
|
Johnson Controls International PLC
|
2.97%
|
29,666,817
|
$119.75
|
+28.58%($153.98)
|
$3,552,601,336
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-7.79% (-2.51M)
|
-0.25%
|
|
|
|
CVS Health Corp
|
2.79%
|
41,991,204
|
$79.36
|
+17.70%($93.41)
|
$3,332,421,949
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-12.92% (-6.23M)
|
-0.41%
|
|
|
|
FedEx Corp
|
2.55%
|
10,559,255
|
$288.86
|
+11.19%($321.19)
|
$3,050,146,399
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-4.44% (-490.5K)
|
-0.12%
|
|
|
|
MetLife Inc
|
2.52%
|
38,238,918
|
$78.94
|
+22.50%($96.70)
|
$3,018,580,187
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-2.57% (-1.01M)
|
-0.07%
|
|
|
|
Alphabet Inc, CL-A
|
2.21%
|
8,460,700
|
$313.00
|
+11.02%($347.50)
|
$2,648,199,100
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-4.99% (-444.7K)
|
-0.12%
|
|
|
|
TAIWAN SEMICONDUCTOR MANUFAC
|
2.10%
|
51,459,000
|
$48.85
|
-64.71%($17.24)
|
$2,513,945,956
|
2025 Q1
|
≈ 1.00 year
|
Common Stock
|
-1.80% (-941K)
|
-0.04%
|
|
|
|
GlaxoSmithKline PLC ADR
|
2.07%
|
50,557,077
|
$49.04
|
+4.15%($51.08)
|
$2,479,319,056
|
2019 Q3
|
≈ 6.50 years
|
Depositary Receipt
|
-13.45% (-7.86M)
|
-0.32%
|
|
|
|
Gilead Sciences Inc
|
2.00%
|
19,505,112
|
$122.74
|
+11.18%($136.46)
|
$2,394,057,447
|
2019 Q3
|
≈ 6.50 years
|
Common Stock
|
-13.80% (-3.12M)
|
-0.32%
|
|
Completely sold out
4 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
EchoStar Corp
|
-8,472,509
|
-0.54%
|
2024 Q1
|
≈ 1.75 years
|
|
|
|
Bank of America Corp
|
-10,676,300
|
-0.46%
|
2019 Q3
|
≈ 6.25 years
|
|
|
|
The Gap, Inc
|
-3,941,972
|
-0.07%
|
2019 Q3
|
≈ 6.25 years
|
|
|
|
SK HYNIX INC
|
-114,320
|
-0.02%
|
2025 Q3
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.